Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Stereotactic Radiosurgery Versus Laser Ablation for Hypothalamic Hamartoma-Related Epilepsy: A Multicenter Retrospective Study

EF 2023-24

Résumé
Hypothalamic hamartomas are rare, congenital brain tumors. The earliest manifestation of the disease is often the childhood-onset of seizures. Up to 80% of patients do not respond to medication, requiring surgery. Without prompt intervention, up to half develop several types of debilitating seizures and severe intellectual disability. Permanent seizure freedom can be achieved through surgical resection of the tumor. However, surgery carries a high risk of permanent deficits such as stroke and memory impairment. Despite aggressive treatment, more than 40% of patients are left with residual seizures and a high likelihood of progressive decline in quality of life. Currently, the choice of treatment depends mainly on personal preferences and availability of techniques at different centers. A large-scale study directly comparing surgical approaches is thus necessary to answer important research questions. The overarching goal of this study is to compare the safety and efficacy of laser ablation and radiosurgery, the most commonly used techniques in the treatment of hypothalamic hamartomas. An international registry of clinical data will be created to collect data on hypothalamic hamartoma patients treated surgically at different centers across the world. The primary goal of this study is to compare the safety and efficacy of laser ablation and radiosurgery for the first time in the medical literature. With a target sample size of 150 participants, this will be the largest surgical cohort of hypothalamic hamartoma patients published to date. The findings of this study could significantly advance our understanding of long-term surgical outcomes of patients and fill important knowledge gaps on the risks and benefits of laser ablation and radiosurgery.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506403
Name
Niazi Farbod
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Stereotactic Radiosurgery Versus Laser Ablation for Hypothalamic Hamartoma-Related Epilepsy: A Multicenter Retrospective Study
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Tumor; Ciliopathy; Congenital Malformation; Hypothalamic Hamartoma; Laser Ablation; Neurosurgery; Pediatric Epilepsy Surgery; Rare Disease; Seizure; Stereotactic Radiosurgery
Abstract
Hypothalamic hamartomas are rare, congenital brain tumors. The earliest manifestation of the disease is often the childhood-onset of seizures. Up to 80% of patients do not respond to medication, requiring surgery. Without prompt intervention, up to half develop several types of debilitating seizures and severe intellectual disability. Permanent seizure freedom can be achieved through surgical resection of the tumor. However, surgery carries a high risk of permanent deficits such as stroke and memory impairment. Despite aggressive treatment, more than 40% of patients are left with residual seizures and a high likelihood of progressive decline in quality of life. Currently, the choice of treatment depends mainly on personal preferences and availability of techniques at different centers. A large-scale study directly comparing surgical approaches is thus necessary to answer important research questions. The overarching goal of this study is to compare the safety and efficacy of laser ablation and radiosurgery, the most commonly used techniques in the treatment of hypothalamic hamartomas. An international registry of clinical data will be created to collect data on hypothalamic hamartoma patients treated surgically at different centers across the world. The primary goal of this study is to compare the safety and efficacy of laser ablation and radiosurgery for the first time in the medical literature. With a target sample size of 150 participants, this will be the largest surgical cohort of hypothalamic hamartoma patients published to date. The findings of this study could significantly advance our understanding of long-term surgical outcomes of patients and fill important knowledge gaps on the risks and benefits of laser ablation and radiosurgery.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Niazi, Farbod
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~